Several entities are partnering to provide £300 million ($506.9 million) to the UK’s 100,000 Genomes Project. The funds are to accomplish the Project’s goal of sequencing 100,000 patient genomes by 2017 from the records of the National Health Service (NHS) to devise personalized-disease and cancer therapies. Illumina will grant £162 million over the next four years to the Project, and Genomics England, a government-owned company, will provide £78 million for Illumina to perform the sequencing. In addition, the NHS will pay £20 million for patient facilities, the medical-research charity Wellcome Trust will spend £27 million on a sequencing facility for Genomics England and the Medical Research Council will provide £24 million for computing for sequence storage and analysis. Since the Project’s 2012 start, hundreds of genomes have been sequenced, and the new funds will facilitate completion of 10,000 more over the next year. Data from the Project will be available to academics and clinicians for research via the Clinical Interpretation Partnership to be developed by Genomics England.

Source: Science